|
|
Gene Symbol |
GSTM1 |
|
Aliases |
GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 |
|
Entrez Gene ID |
|
|
Gene Name |
Glutathione S-transferase mu 1 |
|
Chromosomal Location |
1p13.3 |
|
HGNC ID |
|
|
Summary |
Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Null mutations of this class mu gene have been linked with an increase in a number of cancers, likely due to an increased susceptibility to environmental toxins and carcinogens. Multiple protein isoforms are encoded by transcript variants of this gene. [provided by RefSeq, Jul 2008]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Glutathione S-transferase Mu 1, GST HB subunit 4, GST class-mu 1, HB subunit 4, S-(hydroxyalkyl)glutathione lyase, glutathione S-alkyltransferase, glutathione S-aralkyltransferase, glutathione S-aryltransferase, glutathione S-transferase M1 |
|
Function |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000276571 |
|
P06850 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Atherosclerosis |
|
Raynaud Phenomenon |
|
Raynaud Disease |
|
Digestive System Diseases |
Liver Diseases |
|
Non-alcoholic Fatty Liver Disease |
|
Hepatitis |
|
Endocrine System Diseases |
Diabetes Mellitus |
|
PCOS |
|
Immune System Diseases |
Urticaria |
|
Neoplasms |
Lung Cancer |
|
Liver Cancer |
|
Renal Cancer |
|
Carcinoma |
|
Bladder Cancer |
|
Prostate cancer |
|
Leukemia |
|
Colorectal Cancer |
|
Mesothelioma |
|
Therapy-Associated Neoplasms |
|
Vulvar Cancer |
|
Nervous System Diseases |
Degenerative Diseases Central Nervous System |
|
Parkinson Disease |
|
Psychiatric/Brain disorders |
Mental Depression |
|
Autistic Disorder |
|
Schizophrenia |
|
Bipolar Disorder |
|
Respiratory Tract Diseases |
Asthma |
|
Skin and Connective Tissue Diseases |
Dermatitis |
|
Chloracne |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
CYP1A1, GSTT1 |
|
CYP1A1 (T6235C), GSTM1[-] and GSTT1[-] |
|
Related
|
253 (180 PCO, 72 controls) |
The study concludes that the presence of hyperinducible CYP1A1 (T6235C) mutant genotype and its mutants in combination with GSTM1 and GSTT1 null genotypes might cause an imbalance between phase I and phase II enzymes, and therefore may represent a risk factor for PCO |
|
|
|
|